Novavax Inc (NVAX)

[WovenO2]

Novavax, Inc. (NVAX) REPORT OVERVIEW

Novavax's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Novavax reported revenue of $8.35 vs $3.23 (up 158.50%) and diluted earnings per share -$0.15 vs -$0.24. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Novavax reported revenue of $15.35 vs $36.25 (down 57.65%) and diluted earnings per share -$1.03 vs -$0.60. Novavax is expected to report earnings on February 26th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.21. The estimated EPS forecast for the next fiscal year is -$0.54 and is expected to report on February 26th, 2018.

To read the full Novavax, Inc. (NVAX) report, download it here: http://Fundamental-Markets.com/register/?so=NVAX